X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Clinical Trials News - 08/07/2024 00:07

Genentech to Reintroduce Susvimo for People With Wet Age-Related Macular Degeneration (AMD)

South San Francisco, CA -- July 8, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the reintroduction of Susvimo® (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the...

Articles similaires

Sorry! Image not available at this time

Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss

drugs.com - 17/Oct 21:10

South San Francisco, CA -- October 17, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today results from two...

Sorry! Image not available at this time

Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss

drugs.com - 17/Oct 21:10

South San Francisco, CA -- October 17, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today results from two...

Sorry! Image not available at this time

FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis

drugs.com - 19/Oct 05:10

South San Francisco, CA -- October 19, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food...

Sorry! Image not available at this time

Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types

mangaloremirror.com - 13/Oct 05:41

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will...

Sorry! Image not available at this time

Genentech Data at ESMO 2025 Showcase Advances in Science and Cancer Care Across Multiple Tumor Types

mangaloremirror.com - 13/Oct 05:41

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will...

Sorry! Image not available at this time

Genentech’s Phase III evERA Data Showed Giredestrant Significantly Improved Progression-Free Survival in People With ER-Positive Advanced Breast Cancer

drugs.com - 17/Oct 21:10

South San Francisco, CA -- October 17, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results...

Sorry! Image not available at this time

Genentech’s Phase III evERA Data Showed Giredestrant Significantly Improved Progression-Free Survival in People With ER-Positive Advanced Breast Cancer

drugs.com - 17/Oct 21:10

South San Francisco, CA -- October 17, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results...

Sorry! Image not available at this time

Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a ...

wn.com - 18/Oct 16:32

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the...

Sorry! Image not available at this time

Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a ...

wn.com - 18/Oct 16:32

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the...

Sorry! Image not available at this time

Experts hail ‘remarkable’ success of electronic implant in restoring sight

theguardian.com - 12:00

Sight of 84% of people with form of age-related macular degeneration restored after being fitted with device

Les derniers communiqués